PILOT STUDY SHOWS BLEPHADEX® IS EFFECTIVE IN THE TREATMENT OF DEMODEX MITES
Sep 9, 2019
Unbeknownst to us here at Lunovus, a recent study was conducted by third-party researchers from The School of Optometry & Vision Science, and The University of New South Wales regarding our patented Blephadex Eyelid Wipes.
While we’ve always been assured that our patented formulation comprised of precise concentrations of tea tree oil and coconut oil was effective for keeping users’ eyes comfortable and free of irritants like Demodex, we’re proud to say that our efficacy claims have been confirmed by the positive results of this first-of-its-kind longitudinal study.
A population of 20 subjects were asked to use Blephadex Eyelid Wipes on the same eyelid once daily for 30 days. Conversely, all subjects were instructed to leave the contralateral eyelid untreated over the same period of time to serve as the control.
All participants underwent the same procedures at both the baseline and 30-day follow up visit, and the study recorded progression in a number of relevant variables over the course of a month. These variables include (i.) Demodex Mite Count, (ii.) Ocular Comfort, (iii.) Eyelid Microbiome, (iv.) Tear Quantity and Quality.
- Demodex: When comparing the treated eyes and the untreated eyes, the report states: “a statistically significant reduction in the Demodex county was observed between baseline and the 30-day visit for the treated eyes only.”
- Comfort: Based on the Visual Advantage Scale (VAS), the comfort ratings improved for treated eyes only.
Visual Advantage Scale: 0 = No Symptoms; 100 = Maximum Symptoms
- Day 1 Baseline Median: (VAS = 32)
- Day 30 Follow-Up Median: (VAS = 16)
- Microbiome & (iv.) Tears: Blephadex did not affect the eyelid microbiome, nor the quantity or quality of tears.